65,437 trials
Benign Prostatic Hypertrophy
Primary: IPSS Change From Baseline — -5.6 Units on a scale — p=<0.001
Abdominal Aortic Aneurysm
Primary: Number of Participants Without a Device Related Adverse Events Within 1 Month of the Study Procedure. — 36 Participants
Renal Transplantation
Primary: Renal Function Assessed by Calculated Glomerular Filtration Rate (cGFR) — 57.07; 51.73 mL/min/1.73m^2
Infections, Streptococcal
Primary: Number of Subjects Reporting Grade 3 Adverse Events — 42; 13 Participants
Macular Edema, Cystoid · Retinal Vein Occlusion
Primary: The Number of Study Participants Experiencing an Improvement by 15 or More Letters From Baseline in Best-corrected ETDRS Visual Acuity Score at the 12-month Visit — 5…
Urge Urinary Incontinence · Urinary Frequency
Primary: Change From Baseline in Mean Weekly Frequency of Urinary Incontinence Episodes at Week 12 — -24.8; -21.9; -20.0 Episodes
Bloodloss · Surgical Procedures, Operative
Primary: Cumulative Volume of Packed Red Blood Cells Transfused — 1223.2; 623.5 mL — p=0.001
Benign Prostatic Hypertrophy
Primary: International Prostate Symptom Score (IPSS) — -6.2; -5.1; -5.7 Units on a scale — p=0.371
Hepatitis D, Chronic · Hepatitis B, Chronic
Primary: Number of Participants With a Virological Response — 12; 24; 9; 27 Participants
Candidemia · Invasive Candidiasis
Primary: Number of Participants for Global Response (Based on Clinical and Microbiological Success or Failure) at End of Treatment — 26; 18 participants
Ovarian Neoplasms · Breast Neoplasms · Paresthesia
Primary: Number of Participants Who Received Concomitant Treatment Strategies to Manage Palmar-Plantar Erythrodysesthesia (PPE) — 10; 8; 8; 3 Participants
Attention Deficit Hyperactivity Disorder
Primary: Categorical Changes in Vital Signs (Blood Pressure [BP], Pulse, Weight, Temperature) During the Study — 228; 92; 19; 39 participants
Cardiovascular Disease
Primary: The Number and Percentage of Patients With Death or Life Threatening Cardiopulmonary Events Occurring Following Definity Administration — 0 Participants
Haemophilus Influenzae Type b · Neisseria Meningitidis
Primary: Number of Subjects With Meningococcal Serogroup C Serum Bactericidal Assay Using Rabbit Complement (rSBA-MenC) Titers Equal to or Above Cut-off Value of 1:8 — 44; 93; 0…
Nevi
Primary: Frequency of BRAF Mutations Among Nevi — 6; 19 BRAF mutations